img

Global Fondaparinux Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034


Published on: 2024-01-04 | No of Pages : 320 | Industry : Pharma & Healthcare

Publisher : GRD Survey | Format : PDF

Global Fondaparinux Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Executive Summary

According to GRD Survey data, the global Fondaparinux market is estimated at 410 million US$ in 2021 and is expected to reach 580 million US$ by the end of 2028, growing at a CAGR of 5.0% in the forecast period between 2022 and 2028.

This report studies the Fondaparinux market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Fondaparinux in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Branded Drug
Generics Drug

Market Snapshot, By Application
Clinics
Hospitals
Diagnostic centres
Ambulatory Surgical Centres
Home Care Settings

Main Market Players Analyzed in this report, including
WisMed
Sanofi
Pfizer
Mylan
Kaifeng
GlaxoSmithKline
Eisai
Dr. Reddy’s Laboratories
Bristol
Boehringer Ingelheim
Bayer Healthcare AG
Aspen
Apotex
Alchemia
Abbott India

The study objectives of this report are
To study and analyze the global Fondaparinux market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Fondaparinux market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Fondaparinux manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Fondaparinux market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Fondaparinux submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Fondaparinux are as follows
History Year2016-2020
Base Year2020
Estimated Year2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Fondaparinux Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Fondaparinux Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Fondaparinux

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Fondaparinux Sales Channel and Distributors Analysis
3.3.1 Fondaparinux Sales Channel
3.3.2 Fondaparinux Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Clinics
3.4.2 Major Buyers in Hospitals
3.5 Fondaparinux Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Fondaparinux Type Introduction
4.1.1 Branded Drug
4.1.2 Generics Drug
4.2 Global Fondaparinux Sales by Type 2016-2021
4.3 Global Fondaparinux Revenue by Type 2016-2021
4.4 Global Fondaparinux Price by Type 2016-2021

5 Market Segment: by Application
5.1 Fondaparinux Type Introduction
5.1.1 Clinics
5.1.2 Hospitals
5.1.3 Diagnostic centres
5.1.3 Ambulatory Surgical Centres
5.1.4 Home Care Settings
5.2 Global Fondaparinux Sales by Application 2016-2021
5.3 Global Fondaparinux Revenue by Application 2016-2021
5.4 Global Fondaparinux Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Fondaparinux Market by Region
6.1.1 Global Fondaparinux Sales by Regions
6.1.2 Global Fondaparinux Revenue by Regions
6.2 North America Fondaparinux Market 2016-2021
6.3 Europe Fondaparinux Market 2016-2021
6.4 Asia Pacific Fondaparinux Market 2016-2021
6.5 South America Fondaparinux Market 2016-2021
6.6 Middle East and Africa Fondaparinux Market 2016-2021

7 North America
7.1 North America Fondaparinux Market by Country 2016-2021
7.1.1 North America Fondaparinux Sales by Country
7.1.2 North America Fondaparinux Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Fondaparinux Market by Country 2016-2021
8.1.1 Europe Fondaparinux Sales by Country
8.1.2 Europe Fondaparinux Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Fondaparinux Market by Country 2016-2021
9.1.1 Asia Pacific Fondaparinux Sales by Country
9.1.2 Asia Pacific Fondaparinux Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Fondaparinux Market by Country 2016-2021
10.1.1 South America Fondaparinux Sales by Country
10.1.2 South America Fondaparinux Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Fondaparinux Market by Country 2016-2021
11.1.1 Middle East and Africa Fondaparinux Sales by Country
11.1.2 Middle East and Africa Fondaparinux Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 WisMed
12.1.1 WisMed Company Information
12.1.2 WisMed Fondaparinux Product Portfolio, Specification and Application
12.1.3 WisMed Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 WisMed Key Development
12.2 Sanofi
12.2.1 Sanofi Company Information
12.2.2 Sanofi Fondaparinux Product Portfolio, Specification and Application
12.2.3 Sanofi Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Sanofi Key Development
12.3 Pfizer
12.3.1 Pfizer Company Information
12.3.2 Pfizer Fondaparinux Product Portfolio, Specification and Application
12.3.3 Pfizer Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Pfizer Key Development
12.4 Mylan
12.4.1 Mylan Company Information
12.4.2 Mylan Fondaparinux Product Portfolio, Specification and Application
12.4.3 Mylan Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Mylan Key Development
12.5 Kaifeng
12.5.1 Kaifeng Company Information
12.5.2 Kaifeng Fondaparinux Product Portfolio, Specification and Application
12.5.3 Kaifeng Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Kaifeng Key Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Information
12.6.2 GlaxoSmithKline Fondaparinux Product Portfolio, Specification and Application
12.6.3 GlaxoSmithKline Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 GlaxoSmithKline Key Development
12.7 Eisai
12.7.1 Eisai Company Information
12.7.2 Eisai Fondaparinux Product Portfolio, Specification and Application
12.7.3 Eisai Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 GlaxoSmithKline Key Development
12.9 Bristol
12.9.1 Bristol Company Information
12.9.2 Bristol Fondaparinux Product Portfolio, Specification and Application
12.9.3 Bristol Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Bristol Key Development
12.8 Dr. Reddy’s Laboratories
12.8.1 Dr. Reddy’s Laboratories Company Information
12.8.2 Dr. Reddy’s Laboratories Fondaparinux Product Portfolio, Specification and Application
12.8.3 Dr. Reddy’s Laboratories Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Dr. Reddy’s Laboratories Key Development
12.11 Bayer Healthcare AG
12.11.1 Bayer Healthcare AG Company Information
12.11.2 Bayer Healthcare AG Fondaparinux Product Portfolio, Specification and Application
12.11.3 Bayer Healthcare AG Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 Bayer Healthcare AG Key Development
12.12 Aspen
12.12.1 Aspen Company Information
12.12.2 Aspen Fondaparinux Product Portfolio, Specification and Application
12.12.3 Aspen Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Aspen Key Development
12.13 Apotex
12.13.1 Apotex Company Information
12.13.2 Apotex Fondaparinux Product Portfolio, Specification and Application
12.13.3 Apotex Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
12.13.4 Apotex Key Development
12.14 Alchemia
12.14.1 Alchemia Company Information
12.14.2 Alchemia Fondaparinux Product Portfolio, Specification and Application
12.14.3 Alchemia Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
12.14.4 Alchemia Key Development
12.15 Abbott India
12.15.1 Abbott India Company Information
12.15.2 Abbott India Fondaparinux Product Portfolio, Specification and Application
12.15.3 Abbott India Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
12.15.4 Abbott India Key Development

13 Global Fondaparinux Market Forecast by Region by Type and by Application
13.1 Global Fondaparinux Sales, Revenue Forecast 2022-2027
13.2 Global Fondaparinux Forecast by Regions
13.2.1 Global Fondaparinux Sales Forecast by Region 2022-2027
13.2.2 Global Fondaparinux Revenue Forecast by Region 2022-2027
13.3 Global Fondaparinux Forecast by Type
13.3.1 Global Fondaparinux Sales Forecast by Type 2022-2027
13.3.2 Global Fondaparinux Revenue Forecast by Type 2022-2027
13.3.3 Global Fondaparinux Price Forecast by Type 2022-2027
13.4 Global Fondaparinux Forecast by Application
13.4.1 Global Fondaparinux Sales Forecast by Application 2022-2027
13.4.2 Global Fondaparinux Revenue Forecast by Application 2022-2027
13.4.3 Global Fondaparinux Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer

List of Figure

List of Tables

Table 1: Global Fondaparinux Production Specifications
Table 2: Drivers in Fondaparinux Market
Table 3: Restraints Fondaparinux Market
Table 4: Opportunity in Fondaparinux Market
Table 5: Comparion of Alternative and Fondaparinux
Table 6: Fondaparinux Raw Materials Key Suppliers List
Table 7: Fondaparinux Distributors List
Table 8: Fondaparinux Major Buyers in Clinics
Table 9: Fondaparinux Major Buyers in Hospitals
Table 10: Fondaparinux Major Buyers in Diagnostic centres
Table 11: Global Fondaparinux Sales (K Units) by Type 2016-2021
Table 12: Global Fondaparinux Sales Market Share by Type 2016-2021
Table 13: Global Fondaparinux Revenue (Million USD) by Type 2016-2021
Table 14: Global Fondaparinux Revenue Market Share by Type 2016-2021
Table 15: Global Fondaparinux Price by Type 2016-2021
Table 16: Global Fondaparinux Sales (K Units) by Application 2016-2021
Table 17: Global Fondaparinux Sales Market Share by Application 2016-2021
Table 18: Global Fondaparinux Revenue (Million USD) by Application 2016-2021
Table 19: Global Fondaparinux Revenue Market Share by Application 2016-2021
Table 20: Global Fondaparinux Price by Application 2016-2021
Table 21: Global Fondaparinux Sales (K Units) by Region 2016-2021
Table 22: Global Fondaparinux Sales Market Share by Region 2016-2021
Table 23: Global Fondaparinux Revenue (Million USD) by Region 2016-2021
Table 24: Global Fondaparinux Revenue Market Share by Region 2016-2021
Table 25: North America Fondaparinux Sales (K Units) by Country 2016-2021
Table 26: North America Fondaparinux Sales Market Share by Country 2016-2021
Table 27: North America Fondaparinux Revenue (Million USD) by Country 2016-2021
Table 28: North America Fondaparinux Revenue Market Share by Country 2016-2021)
Table 29: Europe Fondaparinux Sales (K Units) by Country 2016-2021
Table 30: Europe Fondaparinux Sales Market Share by Country 2016-2021
Table 31: Europe Fondaparinux Revenue (Million USD) by Country 2016-2021
Table 32: Europe Fondaparinux Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Fondaparinux Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Fondaparinux Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Fondaparinux Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Fondaparinux Revenue Market Share by Country 2016-2021)
Table 37: South America Fondaparinux Sales (K Units) by Country 2016-2021
Table 38: South America Fondaparinux Sales Market Share by Country 2016-2021
Table 39: South America Fondaparinux Revenue (Million USD) by Country 2016-2021
Table 40: South America Fondaparinux Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Fondaparinux Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Fondaparinux Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Fondaparinux Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Fondaparinux Revenue Market Share by Country 2016-2021)
Table 45 WisMed Company Information
Table 46 WisMed Fondaparinux Product Portfolio, Specification and Application
Table 47 WisMed Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Sanofi Company Information
Table 49 Sanofi Fondaparinux Product Portfolio, Specification and Application
Table 50 Sanofi Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Pfizer Company Information
Table 52 Pfizer Fondaparinux Product Portfolio, Specification and Application
Table 53 Pfizer Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Mylan Company Information
Table 55 Mylan Fondaparinux Product Portfolio, Specification and Application
Table 56 Mylan Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Kaifeng Company Information
Table 58 Kaifeng Fondaparinux Product Portfolio, Specification and Application
Table 59 Kaifeng Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 GlaxoSmithKline Company Information
Table 61 GlaxoSmithKline Fondaparinux Product Portfolio, Specification and Application
Table 62 GlaxoSmithKline Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Eisai Company Information
Table 64 Eisai Fondaparinux Product Portfolio, Specification and Application
Table 65 Eisai Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 Dr. Reddy’s Laboratories Company Information
Table 67 Dr. Reddy’s Laboratories Fondaparinux Product Portfolio, Specification and Application
Table 68 Dr. Reddy’s Laboratories Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 Bristol Company Information
Table 70 Bristol Fondaparinux Product Portfolio, Specification and Application
Table 71 Bristol Fondaparinux Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Fondaparinux Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Fondaparinux Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Fondaparinux Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Fondaparinux Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Fondaparinux Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Fondaparinux Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Fondaparinux Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Fondaparinux Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Fondaparinux Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Fondaparinux Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Fondaparinux Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Fondaparinux Revenue Market Share Forecast by Application (2022-2027)


List of Figures

Figure 1: Fondaparinux Picture
Figure 2: Global Fondaparinux Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Fondaparinux Supply Chain Analysis
Figure 5: Fondaparinux Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Branded Drug
Figure 7: Product Picture of Generics Drug
Figure 8: Global Fondaparinux Sales Market Share by Type, 2020
Figure 9: Global Fondaparinux Revenue Market Share by Type, 2020
Figure 10: Fondaparinux in Clinics
Figure 11: Global Fondaparinux Market: Clinics 2016-2021
Figure 12: Fondaparinux in Hospitals
Figure 13: Global Fondaparinux Market: Hospitals 2016-2021
Figure 14: Global Fondaparinux Sales Market Share by Application, 2020
Figure 15: Global Fondaparinux Revenue Market Share by Application, 2020
Figure 16: Global Fondaparinux Sales Market Share by Region 2016-2021
Figure 17: Global Fondaparinux Revenue Market Share by Region 2016-2021
Figure 18: North America Fondaparinux Sales (K Units) Status 2016-2021
Figure 19: North America Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 20: Europe Fondaparinux Sales (K Units) Status 2016-2021
Figure 21: Europe Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Fondaparinux Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 24: South America Fondaparinux Sales (K Units) Status 2016-2021
Figure 25: South America Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Fondaparinux Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 28: North America Fondaparinux Sales Market Share by Country, 2020
Figure 29: North America Fondaparinux Revenue Market Share by Country, 2020
Figure 30: United States Fondaparinux Sales (K Units) Status 2016-2021
Figure 31: United States Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 32: Canada Fondaparinux Sales (K Units) Status 2016-2021
Figure 33: Canada Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Fondaparinux Sales (K Units) Status 2016-2021
Figure 35: Mexico Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 36: Europe Fondaparinux Sales Market Share by Country, 2020
Figure 37: Europe Fondaparinux Revenue Market Share by Country, 2020
Figure 38: Germany Fondaparinux Sales (K Units) Status 2016-2021
Figure 39: Germany Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 40: France Fondaparinux Sales (K Units) Status 2016-2021
Figure 41: France Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 42: UK Fondaparinux Sales (K Units) Status 2016-2021
Figure 43: UK Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 44: Italy Fondaparinux Sales (K Units) Status 2016-2021
Figure 45: Italy Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 46: Russia Fondaparinux Sales (K Units) Status 2016-2021
Figure 46: Russia Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 47: Spain Fondaparinux Sales (K Units) Status 2016-2021
Figure 48: Spain Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Fondaparinux Sales Market Share by Country, 2020
Figure 50: Asia Pacific Fondaparinux Revenue Market Share by Country, 2020
Figure 51: China Fondaparinux Sales (K Units) Status 2016-2021
Figure 52: China Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 53: Japan Fondaparinux Sales (K Units) Status 2016-2021
Figure 54: Japan Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 55: Korea Fondaparinux Sales (K Units) Status 2016-2021
Figure 56: Korea Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Fondaparinux Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 59: India Fondaparinux Sales (K Units) Status 2016-2021
Figure 60: India Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 61: Australia Fondaparinux Sales (K Units) Status 2016-2021
Figure 62: Australia Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 63: South America Fondaparinux Sales Market Share by Country, 2020
Figure 64: South America Fondaparinux Revenue Market Share by Country, 2020
Figure 65: Brazil Fondaparinux Sales (K Units) Status 2016-2021
Figure 66: Brazil Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Fondaparinux Sales (K Units) Status 2016-2021
Figure 68: Argentina Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Fondaparinux Sales (K Units) Status 2016-2021
Figure 70: Colombia Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Fondaparinux Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Fondaparinux Revenue Market Share by Country, 2020
Figure 73: Turkey Fondaparinux Sales (K Units) Status 2016-2021
Figure 74: Turkey Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Fondaparinux Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Fondaparinux Sales (K Units) Status 2016-2021
Figure 78: South Africa Fondaparinux Revenue (Million USD) Status 2016-2021
Figure 79: WisMed Fondaparinux Revenue Market Share Globally (2019-2021)
Figure 80: Sanofi Fondaparinux Revenue Market Share Globally (2019-2021)
Figure 81: Pfizer Fondaparinux Revenue Market Share Globally (2019-2021)
Figure 82: Mylan Fondaparinux Revenue Market Share Globally (2019-2021)
Figure 83: Kaifeng Fondaparinux Revenue Market Share Globally (2019-2021)
Figure 84: GlaxoSmithKline Fondaparinux Revenue Market Share Globally (2019-2021)
Figure 85: Eisai Fondaparinux Revenue Market Share Globally (2019-2021)
Figure 86: Dr. Reddy’s Laboratories Fondaparinux Revenue Market Share Globally (2019-2021)
Figure 87: Bristol Fondaparinux Revenue Market Share Globally (2019-2021)
Figure 88: Boehringer Ingelheim Fondaparinux Revenue Market Share Globally (2019-2021)
Figure 89: Global Fondaparinux Sales (K Units) Forecast (2022-2027)
Figure 90: Global Fondaparinux Sales (K Units) Forecast (2022-2027)